In vivo, cells undergoing apoptosis are usually recognised and swiftly ingested by macrophages or neighbouring cells acting as semi-professional phagocytes. This review debates evidence that the contents of apoptotic cells represent a danger to the organism, being capable of injuring tissue directly or triggering autoimmune responses, concluding that phagocytic clearance of intact apoptotic cells is a safe disposal route. Indeed, new data suggest that, in certain circumstances, phagocytes ingesting apoptotic cells may actively downregulate inflammatory and immune responses. Consequently, increasing evidence that there may be factors capable of perturbing safe clearance of apoptotic cells in vivo suggests that failure of this process may be a hitherto unrecognised pathogenetic factor in inflammatory and autoimmune diseases. New treatments designed to promote safe phagocytic clearance of dying cells can be anticipated, and it may even prove possible to eliminate unwanted cells by inducing appearance of cell surface`eat me' signals.
Introduction
If an apoptotic cell could talk it would say something simple ± eat me'. Yet the mechanisms by which phagocytes swiftly recognise, ingest and degrade cells dying by apoptosis are apparently complex and remain poorly understood. This is the case for even the best-characterised`eat me' signal, exposure of phosphatidylserine (PS), as admirably reviewed by Valerie Fadok and colleagues (Fadok et al, 1998a) . Some data suggest that the complexities of phagocyte recognition of apoptotic cells implied by in vitro studies may be illusory, merely representing recognition of PS in different contexts (Pradhan et al, 1997) . Nevertheless, we are still faced with a large body of persuasive experiments [reviewed in (Savill, 1997) ] which point to involvement of a number of other`eat me' signals on the surface of apoptotic cells such as sugar changes (Morris et al, 1984; Duvall et al, 1985; Dini et al, 1992; Hall et al, 1994; Dini et al, 1995) and thrombospondin 1 (TSP1) binding sites (Savill et al, 1992a; Stern et al, 1996; Hughes et al, 1997a) . Furthermore, there is good evidence for involvement of a plethora of phagocyte receptors ( Table 1 ). The object of this review is to encourage the reader to turn away for a moment from this daunting in vitro complexity and think instead of the in vivo significance of phagocyte clearance of cells dying by apoptosis. The concepts are summarised in Figure 1 . Much of what follows is necessarily speculative, because we understand so little of how apoptotic cells are cleared in vivo. Indeed, there seem to be more questions than answers:
Could apoptotic cells directly injure tissue?
Since the original descriptions of apoptosis (Kerr et al, 1972; Wyllie et al, 1980) it has been assumed that phagocyte clearance of intact cells dying by apoptosis protects surrounding tissues against uncontrolled leakage of noxious contents from dying cells. Nevertheless, it is not immediately obvious that apoptotic cells should be potentially injurious to neighbouring cells. For example, when undergoing apoptosis, dangerous cells such as neutrophils lose the ability to respond to receptor-mediated stimuli which normally trigger injurious responses such as secretion of toxic granule proteins (Whyte et al, 1993) . Furthermore, a body of work from Fesus and colleagues (Fesus et al, 1987 (Fesus et al, , 1989 (Fesus et al, , 1991 points to membrane protein cross-linking by tissue transglutaminase during apoptosis, suggesting that the contents of apoptotic cells might be safely sealed inside an insoluble keratin-like cocoon (Piredda et al, 1997) . Indeed, in Caenorhabditis elegans nematodes bearing mutations of genes involved in engulfment of unwanted cells dying apoptosis-like developmental deaths, non-ingested cell corpses appear to`hang around' for long periods without obvious disruption of the organism (reviewed in Ellis et al, 1991 and M Hengartner, personal communication) . Lastly, even if non-ingested apoptotic cells were to disintegrate in vivo, it could be argued that there are sound defences against potentially injurious cell contents, ranging from inactivation of the acidic lysosomal hydrolases of the dying cell by the near neutral pH of the interstitium through potent proteinase inhibitors such as a 1 antitrypsin (Campbell and Campbell, 1988) , to the capacity of macrophages and other cells to endocytose dangerous enzymes (Henson and Johnston, 1987) .
However, we adhere to the belief that failure of efficient phagocytic clearance of cells dying by apoptosis will result in tissue injury rather than an inconvenient`cluttering up' of the tissue with tough, non-degradable cell corpses. Firstly, despite transglutaminase-mediated cross-linking of membrane protein, virtually every investigator in the field is familiar with secondary necrosis of apoptotic cells in vitro;
in the absence of phagocytes, apoptotic cells eventually lose capacity to regulate cell volume, so that they swell and burst. Secondly, endocytic defences may not be highly effective; in preliminary co-culture experiments in which macrophage phagocytosis of neutrophils undergoing apoptosis was non-specifically blocked with colchicine, non-ingested apoptotic neutrophils undergoing secondary necrosis released large quantities of the potent degradative enzyme neutrophil elastase which eluded endocytic clearance by macrophages (Kar et al, 1993) . Thirdly, tissue protective mechanisms operating in interstitial fluid may be inactivated. For example, in perturbed tissues in which cells are dying by necrosis interstitial pH falls to levels at which released lysosomal enzymes might be active in the extracellular space (Hunt et al, 1985; Menken, 1956) . Furthermore, in the microenvironment of a perturbed tissue in which cells are dying, there is evidence that proteinase inhibitors may be oxidatively inactivated (Henson and Johnston, 1987) . Finally, although there are other interpretations of the data, administration of anti-Fas antibodies to mice (Ogasawara et al, 1993) probably provides an extreme example of tissue injury consequent (Duvall et al, 1985; Hall et al, 1994; Dini et al, 1995) 2) a v b 3 /TSP/CD36 RGD-bearing fragments (a) of adhesion molecules.
Low interstitial pH (Savill et al, 1990 (Savill et al, , 1992 ) (Savill et al, 1989) 3) PS receptors (b) Antiphospholopid autoantibodies (Price et al, 1996; Savill et al, 1997) Because murine hepatocytes express Fas, the antibody triggered rapid and widespread apoptosis of these cells. Presumably because this unphysiologically large load of apoptotic cells exceeded the local phagocytic clearance capacity, non-ingested apoptotic hepatocytes underwent secondary necrosis, releasing their contents in association with a very severe inflammatory response and the ultimate death of the animals receiving active anti-Fas antibody.
Definitive evidence in support of the potentially injurious nature of apoptotic cells requires experiments which as yet cannot be performed ± specific blockade in vivo of largescale phagocyte clearance of apoptotic cells. However, it will also be important to consider the possibility that the surface of non-ingested apoptotic cells might be dangerous in that exposed PS could trigger undesirable coagulation in vascular spaces (Fadok et al, 1992; Casciola-Rosen et al, 1996) , an outcome supported by our recent observations in a model of glomerular capillary injury in which recruited neutrophils remain intraluminal ± apoptotic cells were usually found within areas of newly formed thrombus (Hughes et al, 1997b) . On balance, therefore, the available evidence supports the assumption that phagocyte clearance of intact cells dying by apoptosis does protect tissues from inflammatory and coagulative injury initiated by cellular constituents. However this conclusion does not address the next question which arises.
Is phagocytosis a safe means of cell clearance?
The generally inconspicuous nature of cell removal by apoptosis leading to phagocytosis has lent weight to the idea that this is a safe means of disposal of unwanted cells. However, a sceptic might point to the fact that uptake of particles normally triggers proinflammatory responses (Nathan, 1987) from macrophages, the professional phagocytes implicated in clearing large loads of apoptotic cells in the liver and spleen, bone marrow, lymph node and inflamed site. Indeed, the possibility that uptake of apoptotic cells may trigger proinflammatory responses from ingesting phagocytes finds support in reports that cells dying by apoptosis may fix complement, opsonising apoptotic cells for macrophage receptors which may be coupled to secretion of inflammatory mediators (Takizawa et al, 1996) .
However, uptake of large numbers of apoptotic cells fails to stimulate pro-inflammatory secretory responses from cultured monocyte-derived macrophages and glomerular mesangial cells (Meagher et al, 1992; Stern et al, 1996; Hughes et al, 1997a; Fadok et al, 1998b) . In no case have phagocytes been observed to release any of a wide range of potentially injurious mediators, including granule enzymes, thromboxane, tumour necrosis factor-a (TNFa) and chemokines. This lack of response was not due to some toxic effect of ingested apoptotic cells upon macrophages, since appropriate responses were observed if a second stimulus such as opsonised zymosan was used, or if apoptotic cells were deliberately opsonised for macrophage immunoglobulin or complement receptors (Meagher et al, 1992) . Indeed, evidence is now accumulating that when macrophages which have been deliberately stimulated with agents such as lipopolysaccharide take up apoptotic cells, far from pro-inflammatory responses, one observes anti-inflammatory' phenomena. These include down-regulation of LPS-stimulated macrophage release of TNFa and increased secretion of interleukin-10 (IL10), which amongst other immunosuppressive effects is capable of`deactivating' macrophages Voll et al, 1997; Fadok et al, 1998) . Thus, despite the fact that uptake of particles generally leads to activation of phagocytes, there are now compelling in vitro data to suggest that recognition and uptake of intact apoptotic cells is likely to be a safe means of disposal which is uncoupled from inflammatory responses. In vivo support for this idea is so far indirect but strong; in organs such as the thymus, macrophages can ingest massive numbers of apoptotic cells in the absence of inflammation (Surh and Sprent, 1994) . However, we need to consider how tissues might be protected should`front line' mechanisms for clearing apoptotic cells fail.
Are back-up clearance mechanisms available?
So far we have presented arguments that apoptosis leading to phagocyte clearance is a safe way of deleting unwanted dying cells, which if allowed to disintegrate might injure tissue. Indeed, some data suggest that this could be doubly deleterious. Thus, if macrophages were`fed' cell debris from cultured eosinophils which had been allowed to proceed through constitutive apoptosis to secondary necrosis, proinflammatory responses were elicited . Consequently, one might wonder whether capacity to clear apoptotic cells in vivo might not be`backed up' in some way.
Tissues may be able to recruit capacity to ingest intact apoptotic cells in a number of ways. Firstly, many cell types may be able to participate in the clearance job. In the inflamed glomerulus, for example, it is possible that mesangial cells back up macrophages (Savill et al, 1992b; Baker et al, 1994; Hughes et al, 1997) , while in the developing nervous system a number of cell types, including neuronal and glial cells, exhibit capacity to ingest apoptotic cells (Chu-Wang and Oppenheim, 1978; Ashwell, 1990; Parnaik, 1998) . Secondly, local conditions may give phagocytes a boost ± such as the potentiating effects of various inflammatory cytokines upon uptake of apoptotic cells by cultured macrophages or via ligation of CD44 (Hart et al, 1997) . Thirdly, there is the interesting possibility that dying cells might emit`come hither' signals to phagocytes in order selectively to recruit more clearance capacity. This idea is difficult to test either in vitro or in vivo, because death in any cell population tends to be asynchronous, so that a few cells undergoing secondary necrosis might generate chemotactic signals either directly or indirectly by acting on healthy cells. Consequently, observations that phagocytes migrate towards groups of cells undergoing apoptosis must be treated with some caution (Parnaik, 1998) .
However, quite apart from increasing the numbers of hunter' phagocytes in a tissue undergoing large-scale death by apoptosis, it might also be possible to prevent dangerous leakage of contents from dying cells by equipping the`prey' with additional means of being captured and eaten. To date there has been little systematic study of display of`eat me' signals as dying cells progress through apoptosis toward secondary necrosis. Although in some cell types PS exposure may precede nuclear changes of apoptosis by several hours (reviewed in Fadok et al, 1998a) , in the case of well-studied phagocytic targets such as cultured neutrophils undergoing constitutive apoptosis, PS exposure seems more or less synchronous with display of TSP1 binding sites recognisable to macrophages employing the a v b 3 vitronectin receptor/TSP1/CD36 phagocytic mechanism . Nevertheless, constitutive apoptosis in cultured neutrophils does afford the opportunity to study phagocyte recognition of intact cells which are`post-apoptotic' in that they are undergoing late degradative changes such as the loss of nuclear structures identified by He Â bert et al (1996) as`nuclear evanescence'. We have succeeded in purifying such cells and have discovered that they are recognised by a novel mechanism involving a v b 3 and TSP1 but not CD36, even when being taken up by murine thioglycollate-elicited peritoneal macrophages, which predominantly employ PS receptors in uptake of`early' apoptotic cells .
Thus, there is clear evidence that during death by apoptosis, cells can display a temporally defined series of eat me' signals which provide phagocytes with the opportunity to deploy a hierarchy of recognition mechanisms which can be regarded as a series of protective`backups'. Indeed, the possible last line of tissue defence represented by CD36-independent a v b 3 /TSP-mediated macrophage recognition of`post-apoptotic' neutrophils appears also to be uncoupled from pro-inflammatory responses (Ren and Savill, unpublished data) . Nevertheless, given that CD36 may be needed for production of immunosuppressive IL10 (Voll et al, 1997) and that professional antigen presenting cells such as dendritic cells deploy a CD36 independent a v -mediated recognition mechanism in uptake of apoptotic cells , these data stimulate a fourth important question -
Could cells dying by apoptosis trigger undesirable immune responses?
In addition to having capacity to injure tissues directly, the contents of cells dying by apoptosis also have potential to trigger undesirable immune responses. Firstly, apoptotic cell contents might act as non-specific adjuvants, since free oligonucleosomes (generated in dying cells by apoptotic endonucleases) can stimulate DNA and immunoglobulin synthesis in viable lymphocytes (Bell and Morrison, 1991) . Secondly, in individuals with pre-existing autoimmune disease, cell death by apoptosis may be dangerous in that auto antigens may become more accessible. For example, Rosen's group demonstrated beautifully that important nuclear autoantigens such as Ro and La may be selectively redistributed into cell surface blebs which can detach as apoptotic bodies (Casciola-Rosen et al, 1994) . Failed phagocytic clearance and release of autoantigen from disintegrating apoptotic bodies could potentiate presentation of constituent autoantigenic peptides. Thirdly, the Rosen group have also made the fascinating suggestion that during apoptosis enzymes such as caspases may degrade cellular proteins and thereby generate fragments which represent neoantigens capable of triggering autoimmune responses in susceptible individuals (Casciola-Rosen et al, 1995) .
However, at the time of writing there has been very little study of the immunological consequences of phagocyte ingestion of cells dying by apoptosis. The importance of such work has been re-emphasised by the recent discovery that in addition to copious reports of phagocytosis by activated macrophages known to express class II MHC, dendritic cells can also ingest apoptotic cells . Until very recently, we have had little data beyond the intriguing study of Griffith and colleagues (Griffith et al, 1996) , which is open to several interpretations. Administration of antigen-coupled cells into the eye demonstrated that systemic immunity developed of these cells died by necrosis, but not if the administered cells died by apoptosis and were cleared by phagocytes ± tolerance to the antigen was observed. However, using monocytes induced into apoptosis by infection with influenza virus, Albert and colleagues have made the extremely interesting observation that uptake of such cells by dendritic cells leads to MHC class I presentation of influenza peptides derived from the`apoptotic meal' and induction of appropriately restricted CD8+ve T cells (Albert et al, 1998) . Nevertheless, uptake of apoptotic monocytes bearing influenza antigen by monocyte-derived macrophages, rather than dendritic cells, failed to elicit cytolytic T cells, as one might expect from the Griffith study.
We urgently need further work on whether particular phagocyte populations can present peptides derived from ingested dying cells are presented via MHC class I and class II molecules to T cells, and if so whether this occurs in a context likely to stimulate T cell proliferation or anergy; the capacity to present antigens derived from apoptotic cells may prove limited to the most professional of antigen presenting cells, the dendritic cell. However, these experiments will require careful attention to detail, employing well-defined populations of`target' apoptotic or postapoptotic cells, since it will be important to exclude confounding cytokine production consequent upon uptake of debris from apoptotic cells undergoing secondary necrosis. Indeed, if we are to take proper account of possible co-stimulatory signals, another question must be addressed.
What might perturb safe phagocytic clearance of apoptotic cells?
Lack of data means that this must be the most speculative section of an article with more questions than answers. In vitro data, much of a preliminary nature, suggests that a number of factors could block clearance of apoptotic cells in vivo (Table  1) . Antiphospholipid autoantibodies (aPL) were first described in 20 ± 40% of patients with systemic lupus erythematosus (SLE) as anti-cardiolipin antibodies, but are now known to occur in a number of related autoimmune conditions (Hughes and Khamashta, 1994) . The role of aPL in disease pathogenesis remains uncertain, but aPL are known to recognise a complex of the plasma protein b 2 glycoprotein I (b 2 GPI) with anionic phospholipids including phosphatidylserine, which is exposed by apoptotic cells. Importantly, as one might expect, Levine's group (Price et al, 1996) have confirmed that aPL can bind to apoptotic but not normal cells in a b 2 GPI-dependent manner. A number of laboratories are now investigating the possibility that this may perturb safe clearance of apoptotic cells, either by opsonising apoptotic cells so that macrophages incite inflammation or autoimmunity (Manfredi et al, 1998) , or by blocking clearance by phagocytes which do not bear receptors for opsonic immunoglobulin . This line of enquiry emphasises that some factors perturbing clearance of apoptotic cells might also have synergistically deleterious effects. Consequently, the physician might ask a final question.
Could safe clearance of apoptotic cells be promoted for therapeutic gain?
Again, the available data only allow a speculative answer, but there does seem some prospect of being able to enhance clearance of apoptotic cells (Table 2 ). This could represent a novel approach to therapy of inflammatory and autoimmune disorders. Furthermore, concomitant promotion of safe phagocytic clearance might be an important adjunct to possible future therapies designed to eliminate dangerous or unwanted cells, such as tumour cells, by triggering apoptosis. Indeed, such therapies could be based on directing unscheduled phagocytosis of unwanted cells, by inducing them to express`eat me' signals without undergoing programmed cell death. We have been encouraged by preliminary studies (Knepper-Nicolai et al, 1996) which suggest that hidden within the apparently single program of apoptosis there may be a partially independent program controlling cell surface changes, which might be amenable to selective triggering.
Conclusions
Before we can appreciate the full significance of the familiar phenomenon of swift phagocytic clearance in vivo of cells dying by apoptosis, we need a much more sophisticated understanding of the recognition systems involved and their position in a putative hierarchy of disposal mechanisms. Nevertheless, there are now tantalising clues that perturbed clearance may be a hitherto unrecognised factor in the pathogenesis of inflammatory and autoimmune diseases. Indeed, it may prove possible to design therapies which enhance or even direct safe phagocytic clearance of unwanted or dangerous cells. CD44 ligation (Hart et al, 1997) Glucocorticoids (Liu et al, 1997) 2) Enhance semi-professional phagocytosis Cytokines (Bennett et al, 1995) Glucocorticoids (Liu et al, 1997) CD36 gene transfer Clearance of cells dying by apoptosis Y Ren and J Savill
